RxDoctor Payments Data

Alexander Reiner, MD

Family Medicine · Pickerington, OHNPI 1861831497

Payments from drug & device makers

$4,628in general payments, 2019–2025

Across 316 payments — averaging $14.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$780
  • AstraZeneca$470
  • AbbVie$384
  • Lilly USA, LLC$339
  • Pfizer$333
  • GSK$210
  • plus $2K from 37 others

What the payments were for

  • Food & beverage$4,614100%
  • Education$140%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,628 in reported general payments places this provider in the 85th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$65,825
Medicare patients
183
Services billed
648

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban107$130,680
TrulicityDulaglutide99$127,547
Trelegy ElliptaFluticasone/Umeclidin/Vilanter86$81,084
MounjaroTirzepatide67$79,658
OzempicSemaglutide64$75,806
JardianceEmpagliflozin41$50,095
JanuviaSitagliptin Phosphate26$39,152
RexultiBrexpiprazole12$27,887
XareltoRivaroxaban24$23,257
Breo ElliptaFluticasone/Vilanterol29$20,530
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog25$15,937
LinzessLinaclotide11$15,800
Breztri AerosphereBudesonide/Glycopyr/Formoterol18$13,123
MyrbetriqMirabegron14$10,704
Atorvastatin Calcium695$8,953

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$339$207,205166 claims
PfizerEliquis$333$130,680107 claims
GSKTrelegy Ellipta, Breo Ellipta$210$101,614115 claims
Novo NordiskOzempic$780$75,80664 claims
Boehringer IngelheimJardiance$14$50,09541 claims
MerckJanuvia$136$39,15226 claims
Otsuka America Pharmaceutical, Inc.Rexulti$98$27,88712 claims
Johnson & JohnsonXarelto$116$23,25724 claims
AbbVieLinzess$384$15,80011 claims
AstraZenecaBreztri Aerosphere$470$13,12318 claims
Astellas Pharma US IncMyrbetriq$180$10,70414 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$15$2,787249 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Pickerington

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →